FDA Approves First Targeted Radioligand Therapy for Metastatic Prostate Cancer — Almost 40% survival improvement with Pluvicto for PSMA-expressing CRPC Prostate Cancer Research, ResearchVipul PatelApril 22, 2025Research, Prostate Cancer Research, FDA
FDA Clears Phase 1 Trial of ARV-110 for Advanced Prostate Cancer Education, Men's Health, Prostate Cancer Awareness, Prostate Cancer Education, Prostate Cancer ResearchVipul PatelJanuary 22, 2020FDA, prostate cancer treatments, Prostate Cancer Awareness, prostate cancer
